Chronic kidney disease: open trials in Canada

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  Edmonton · Etobicoke · Halifax · Laval · London · Montreal · Oshawa · Québec · Saint John · Sarnia · Surrey · Toronto · Vancouver · Waterloo · Winnipeg

  Registry updated 2026-11-06

• NCT07241390

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Centricity Research Brampton Endocrinology, Brampton · Cambridge Cardiac Care Centre, Cambridge · Ecogene-21, Chicoutimi · Premier Clinical Trial Network, Hamilton · The Wharton Medical Clinic Clinical Trials Inc, Hamilton · THEO Medical Concorde, Laval · G A Research Associates, Moncton · Applied Medical Informatics Research, Montreal · Diex Recherche Inc. Division Quebec, Québec · CHU de Quebec-Universite Laval-Hotel Dieu de Quebec, Québec · Bluewater Clinical Research Group Inc., Sarnia · Heart Health Institute - Scarborough Office, Scarborough · Kidney Care Centre - Surrey, Surrey · Diex Recherche Inc. Division Trois-Rivieres, Trois-Rivières · C.I.C. Mauricie inc., Trois-Rivières · Clinical Research Solutions - Kitchener, Waterloo · Winchester District Memorial Hospital, Winchester · Glanz Medicine Professional Corporation, Windsor · Seven Oaks General Hospital, Winnipeg

  Registry updated 2026-11-04

• NCT06823115

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  Research · Indiana University

  Alberta Children's Hospital - University of Calgary, Calgary · Stollery Children'S Hospital, Edmonton · McMaster Children's Hospital, Hamilton · McGill University, Montreal · Mount Sinai Hospital, Toronto · Sunnybrook Health Sciences Center, Toronto · The Hospital for Sick Children, Toronto · British Columbia Children's Hospital, Vancouver

  Registry updated 2026-10-28

• NCT07059962

  Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

  Research · Bodyport Inc.

  St. Joseph's Health Centre, Toronto · St. Michael's Hospital, Toronto · Seven Oaks General Hospital, Winnipeg

  Registry updated 2026-10-22

• NCT07187830

  Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

  Research · University of Alberta

  Mazankowski Alberta Heart Institute, Edmonton

  Registry updated 2026-10-07

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Oshawa

  Registry updated 2026-10-05

• NCT07858331

  Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access

  Trial Treatment · Phase 4 · Kristin Clemens

  London Health Sciences Centre, London · St. Joseph's Health Care, London

  Registry updated 2026-10-05

• NCT04098354

  Telemonitoring of Hypertensive Patients With Chronic Kidney Disease

  Trial Treatment · University of Alberta

  University of Alberta, Edmonton

  Registry updated 2026-09-29

• NCT05457283

  A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

  Trial Treatment · Phase 3 · Bayer

  Alberta Children's Hospital | Nephrology Clinic, Calgary · Centre hospitalier universitaire Sainte-Justine | Cardiology, Montreal

  Registry updated 2026-09-24

• NCT06660277

  DIALysis With EXpanded Solute Removal

  Trial Treatment · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  London Health Sciences Centre, London · Orillia Soldiers' Memorial Hospital, Orillia · The Ottawa Hospital, Ottawa

  Registry updated 2026-09-24

• NCT07624305

  A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  Trial Treatment · Phase 3 · AstraZeneca

  Brampton · Calgary · Edmonton · Greater Sudbury · Halifax · London · Mississauga · Montreal · Oakville · Québec · Toronto · Waterloo · Winnipeg

  Registry updated 2026-09-24

• NCT05485961

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Trial Treatment · Phase 2/3 · CSL Behring

  University of Alberta Hospital, Edmonton · Queen Elizabeth II, Health Sciences Centre, Halifax · St. Josephs Healthcare Hamilton, Hamilton · Kingston Health Sciences Centre, Kingston · London Health Sciences Centre, University Hospital, London · Hospital Charles Lemoyne, Longueuil · McGill University Health Centre, Montreal · Hôpital du Sacré-Cœur de Montréal, Montreal · Maisonneuve-Rosemont Hospital, Montreal · CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal · Lakeridge Health Oshawa, Oshawa · The Ottawa Hospital Research Institute, Ottawa · Ciussse-Chus, Sherbrooke · St. Michaels Hospital, Toronto · St Paul Hospital, Vancouver · Seven Oaks Hospital, Winnipeg

  Registry updated 2026-09-21

• NCT05726526

  CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

  Trial Treatment · University of Manitoba

  London Health Sciences Centre, London · Scarborough Health Network - General Hospital, Scarborough Village · St. Boniface Hospital, Winnipeg · Health Sciences Centre, Winnipeg · Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg

  Registry updated 2026-09-10

• NCT07753993

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  Trial Treatment · Phase 3 · AstraZeneca

  Calgary · Edmonton · London · Montreal · Saint John · Scarborough Village · Sherbrooke · Toronto · Vancouver · Waterloo · Winnipeg

  Registry updated 2026-09-09

• NCT07434791

  Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)

  Trial Treatment · Sunnybrook Health Sciences Centre

  Sunnybrook Health Sciences Centre, Toronto

  Registry updated 2026-09-04

• NCT03573089

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  Trial Treatment · The University of Queensland

  Foothills Hospital/ U of Calgary, Calgary · Alberta Health Services, Edmonton · Dalhousie University, Halifax · Queen's University, Kingston · London Health Sciences Centre, London · The Charles Lemoyne Hospital, Longueuil · CHUM, Montreal · Hôpital Maisonneuve-Rosemont, Montreal · Sacre Coeur Hospital, Montreal · McGill University Health Centre, Montreal · Jewish General Hospital, Montreal · Sunnybrook Health Sciences Centre, North York · Oakville Trafalgar Memorial Hospital, Oakville · Orillia Soldier's Memorial Hospital, Orillia · Lakeridge Health, Oshawa · The Ottawa Hospital, Ottawa · CHU de Quebec-Universite Laval, Québec · Red Deer Hospital;, Red Deer · Prairie Vascular Research Inc., Regina · Mackenzie Health, Richmond Hill · Scarborough Hospital Network, Scarborough Village · Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke · Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke · University Health Network - University of Toronto, Toronto · St. Joseph's Healthcare Hamilton, Toronto · Michael Garron Hospital, Toronto · Humber River Hospital, Toronto · St. Joseph's Healthcare Toronto, Toronto · St. Michael's Hospital, Toronto · Trillium Health Partners, Toronto · St. Paul's Hospital, Vancouver · Vancouver General Hospital, Vancouver · St. Boniface General Hospital, Winnipeg

  Registry updated 2026-08-26

• NCT07775482

  Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial

  Trial Treatment · Jean-Maxime Côté

  Centre Hospitalier de l'Université de Montréal, Montreal

  Registry updated 2026-08-20

• NCT07772856

  Liberalizing Potassium Restrictions in Patients Receiving Hemodialysis

  Trial Treatment · University of Ontario Institute of Technology

  St. Michael's Hospital, Unity Health Toronto, Toronto

  Registry updated 2026-08-19

• NCT07724288

  Designing and Implementing a Safety Net Surveillance Program for High Risk CKD

  Trial Treatment · University of Manitoba

  University of Manitoba, Winnipeg

  Registry updated 2026-08-17

• NCT07738731

  Dialysis Less Frequently in the Elderly

  Trial Treatment · Queen's University

  Dalhousie University, Halifax · Queen's University, Kingston · Hôpital du Haut-Richelieu, Montreal · CHUM, Montreal · McGill University, Montreal · Hopital Maisoneuve-Rosemont, Montreal · Hopital Du Sacre Coeur de Montreal, Montreal · Centre de Recherche du CHU de Quebec: Laval University, Québec · Memorial University, St. John's · Vancouver

  Registry updated 2026-07-31

• NCT06396416

  Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

  Trial Treatment · Phase 4 · Western University, Canada

  London Health Sciences Centre, London

  Registry updated 2026-06-29

• NCT07017270

  Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

  Trial Treatment · Phase 4 · Unity Health Toronto

  Unity Health Toronto, Toronto

  Registry updated 2026-06-26

• NCT05822609

  Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

  Trial Treatment · Phase 2 · University of Washington

  Toronto General Hospital, University Health Network, Toronto

  Registry updated 2026-06-02

• NCT06337838

  Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

  Trial Treatment · Phase 3 · Hamilton Health Sciences Corporation

  London Health Sciences Centre, London · Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal · McGill University University Health Centre, Montreal

  Registry updated 2026-05-22

• NCT06920927

  Feasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid

  Trial Treatment · University of Calgary

  Foothills Medical Centre, Calgary · University of Alberta Hospital, Edmonton

  Registry updated 2026-05-14

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error